Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Iron Regulation of Pancreatic Beta-Cell Functions and Oxidative Stress.

Backe MB, Moen IW, Ellervik C, Hansen JB, Mandrup-Poulsen T.

Annu Rev Nutr. 2016 Jul 17;36:241-73. doi: 10.1146/annurev-nutr-071715-050939. Epub 2016 May 4. Review.

PMID:
27146016
2.

Extended structure-activity study of thienopyrimidine-based EGFR inhibitors with evaluation of drug-like properties.

Bugge S, Buene AF, Jurisch-Yaksi N, Moen IU, Skjønsfjell EM, Sundby E, Hoff BH.

Eur J Med Chem. 2016 Jan 1;107:255-74. doi: 10.1016/j.ejmech.2015.11.012. Epub 2015 Nov 11.

PMID:
26599532
3.

The Norwegian Hearing in Noise Test for Children.

Myhrum M, Tvete OE, Heldahl MG, Moen I, Soli SD.

Ear Hear. 2016 Jan-Feb;37(1):80-92. doi: 10.1097/AUD.0000000000000224.

PMID:
26462169
4.

Anti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumors.

Moen I, Gebre M, Alonso-Camino V, Chen D, Epstein D, McDonald DM.

Clin Exp Metastasis. 2015 Dec;32(8):799-817. doi: 10.1007/s10585-015-9752-z. Epub 2015 Oct 7.

5.

Truncated structures used in search for new lead compounds and in a retrospective analysis of thienopyrimidine-based EGFR inhibitors.

Bugge S, Moen IU, Sylte KO, Sundby E, Hoff BH.

Eur J Med Chem. 2015 Apr 13;94:175-94. doi: 10.1016/j.ejmech.2015.03.004. Epub 2015 Mar 4.

PMID:
25768701
6.

Iron: the hard player in diabetes pathophysiology.

Hansen JB, Moen IW, Mandrup-Poulsen T.

Acta Physiol (Oxf). 2014 Apr;210(4):717-32. doi: 10.1111/apha.12256. Review.

PMID:
24521359
7.

EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis.

Talasila KM, Soentgerath A, Euskirchen P, Rosland GV, Wang J, Huszthy PC, Prestegarden L, Skaftnesmo KO, Sakariassen PØ, Eskilsson E, Stieber D, Keunen O, Brekka N, Moen I, Nigro JM, Vintermyr OK, Lund-Johansen M, Niclou S, Mørk SJ, Enger PO, Bjerkvig R, Miletic H.

Acta Neuropathol. 2013 May;125(5):683-98. doi: 10.1007/s00401-013-1101-1. Epub 2013 Feb 22.

8.

Hyperbaric oxygen therapy and cancer--a review.

Moen I, Stuhr LE.

Target Oncol. 2012 Dec;7(4):233-42. doi: 10.1007/s11523-012-0233-x. Epub 2012 Oct 2. Review.

9.

Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation.

Moen I, Jevne C, Wang J, Kalland KH, Chekenya M, Akslen LA, Sleire L, Enger PØ, Reed RK, Øyan AM, Stuhr LE.

BMC Cancer. 2012 Jan 17;12:21. doi: 10.1186/1471-2407-12-21.

10.

Dietary intake and nutritional status in a Scandinavian adult cystic fibrosis-population compared with recommendations.

Moen IE, Nilsson K, Andersson A, Fagerland MW, Fluge G, Hollsing A, Gilljam M, Mared L, Pressler T, Santi H, Storrøsten OT, Hjelte L.

Food Nutr Res. 2011;55. doi: 10.3402/fnr.v55i0.7561. Epub 2011 Nov 17.

11.

Vitamin D deficiency as a risk factor for cystic fibrosis-related diabetes in the Scandinavian Cystic Fibrosis Nutritional Study.

Pincikova T, Nilsson K, Moen IE, Fluge G, Hollsing A, Knudsen PK, Lindblad A, Mared L, Pressler T, Hjelte L; Scandinavian Cystic Fibrosis Study Consortium (SCFSC).

Diabetologia. 2011 Dec;54(12):3007-15. doi: 10.1007/s00125-011-2287-1. Epub 2011 Sep 7.

PMID:
21901282
12.

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma.

Keunen O, Johansson M, Oudin A, Sanzey M, Rahim SA, Fack F, Thorsen F, Taxt T, Bartos M, Jirik R, Miletic H, Wang J, Stieber D, Stuhr L, Moen I, Rygh CB, Bjerkvig R, Niclou SP.

Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3749-54. doi: 10.1073/pnas.1014480108. Epub 2011 Feb 14.

13.

Inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional Study.

Pincikova T, Nilsson K, Moen IE, Karpati F, Fluge G, Hollsing A, Knudsen PK, Lindblad A, Mared L, Pressler T, Hjelte L; Scandinavian Cystic Fibrosis Study Consortium.

Eur J Clin Nutr. 2011 Jan;65(1):102-9. doi: 10.1038/ejcn.2010.194. Epub 2010 Sep 22.

PMID:
20859300
14.

Assessing prosodic skills in five European languages: cross-linguistic differences in typical and atypical populations.

Peppé SJ, Martínez-Castilla P, Coene M, Hesling I, Moen I, Gibbon FE.

Int J Speech Lang Pathol. 2010 Feb;12(1):1-7.

PMID:
20380244
15.

Hyperoxia increases the uptake of 5-fluorouracil in mammary tumors independently of changes in interstitial fluid pressure and tumor stroma.

Moen I, Tronstad KJ, Kolmannskog O, Salvesen GS, Reed RK, Stuhr LE.

BMC Cancer. 2009 Dec 17;9:446. doi: 10.1186/1471-2407-9-446.

16.

Semi-spontaneous oral text production: measurements in clinical practice.

Lind M, Kristoffersen KE, Moen I, Simonsen HG.

Clin Linguist Phon. 2009 Dec;23(12):872-86. doi: 10.3109/02699200903040051.

PMID:
20001304
17.

Combined anti-angiogenic therapy targeting PDGF and VEGF receptors lowers the interstitial fluid pressure in a murine experimental carcinoma.

Kłosowska-Wardega A, Hasumi Y, Burmakin M, Ahgren A, Stuhr L, Moen I, Reed RK, Rubin K, Hellberg C, Heldin CH.

PLoS One. 2009 Dec 4;4(12):e8149. doi: 10.1371/journal.pone.0008149.

18.

Atrial natriuretic peptide modulation of albumin clearance and contrast agent permeability in mouse skeletal muscle and skin: role in regulation of plasma volume.

Curry FR, Rygh CB, Karlsen T, Wiig H, Adamson RH, Clark JF, Lin YC, Gassner B, Thorsen F, Moen I, Tenstad O, Kuhn M, Reed RK.

J Physiol. 2010 Jan 15;588(Pt 2):325-39. doi: 10.1113/jphysiol.2009.180463. Epub 2009 Nov 30.

19.

Hyperoxic treatment induces mesenchymal-to-epithelial transition in a rat adenocarcinoma model.

Moen I, Øyan AM, Kalland KH, Tronstad KJ, Akslen LA, Chekenya M, Sakariassen PØ, Reed RK, Stuhr LE.

PLoS One. 2009 Jul 28;4(7):e6381. doi: 10.1371/journal.pone.0006381.

20.

Brain dynamics of word familiarization in 20-month-olds: effects of productive vocabulary size.

Torkildsen Jv, Friis Hansen H, Svangstu JM, Smith L, Simonsen HG, Moen I, Lindgren M.

Brain Lang. 2009 Feb;108(2):73-88. doi: 10.1016/j.bandl.2008.09.005. Epub 2008 Oct 23.

PMID:
18950850

Supplemental Content

Support Center